Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 5581 to 5595 of 8314 results

  1. Creatinine-based estimate of eGFR – improving accuracy of calculations: In adults, children and young people from black, Asian and other minority ethnic groups with CKD living in the UK, what biomarkers or factors, other than ethnicity, improve the diagnostic accuracy of eGFR calculations?

    Recommendation ID NG203/2 Question Creatinine-based estimate of eGFR – improving accuracy of calculations: In adults, children and young

  2. Femoral component design: In adults undergoing hemiarthroplasty for displaced intracapsular hip fracture (including in different subgroups), which femoral component design has the best long-term outcomes?

    Recommendation ID CG124/07 Question Femoral component design: In adults undergoing hemiarthroplasty for displaced intracapsular hip fracture

  3. Indications for interventions – CT or MRI: In adults with aortic or primary mitral regurgitation in whom the need for intervention is unclear after echocardiography, what is the prognostic value and cost effectiveness of cardiac MRI to assess the severity of valvular regurgitation?

    Recommendation ID NG208/08 Question Indications for interventions – CT or MRI: In adults with aortic or primary mitral regurgitation in

  4. Use of hearing aids and incidence of dementia:- In adults with hearing loss, does the use of hearing aids reduce the incidence of dementia?

    Recommendation ID NG98/3 Question Use of hearing aids and incidence of dementia:- In adults with hearing loss, does the use of hearing

  5. Indications for interventions – global longitudinal strain: In adults with asymptomatic, severe aortic regurgitation or mitral regurgitation what is the prognostic value and cost effectiveness of B‑type natriuretic peptide (BNP) to assess the need for intervention?

    Recommendation ID NG208/13 Question Indications for interventions – global longitudinal strain: In adults with asymptomatic, severe aortic

  6. Indications for interventions – CT or MRI: In adults with asymptomatic severe aortic stenosis what is the prognostic value and cost effectiveness of LVEF measured on cardiac MRI to assess the need for intervention?

    Recommendation ID NG208/10 Question Indications for interventions – CT or MRI: In adults with asymptomatic severe aortic stenosis what

  7. Indications for interventions – global longitudinal strain: In adults with severe heart valve disease what is the prognostic value and cost effectiveness of global longitudinal strain to assess the need for intervention?

    Recommendation ID NG208/12 Question Indications for interventions – global longitudinal strain: In adults with severe heart valve disease

  8. Phosphate binders: In adults with stage 4 or 5 CKD, including those on dialysis, what is the clinical and cost effectiveness and safety of long-term calcium acetate combined with magnesium carbonate for controlling serum phosphate?

    Recommendation ID NG203/17 Question Phosphate binders: In adults with stage 4 or 5 CKD, including those on dialysis, what is the clinical

  9. Indications for interventions – CT or MRI: In adults with asymptomatic severe tricuspid regurgitation what is the prognostic value and cost effectiveness of cardiac MRI for assessment of the right ventricle to assess the need for intervention?

    Recommendation ID NG208/11 Question Indications for interventions – CT or MRI: In adults with asymptomatic severe tricuspid regurgitation

  10. Anticoagulation and antiplatelet therapy: In adults with biological valve replacement, what effect does anticoagulation or antiplatelet therapy have on long-term valve function and outcomes?

    Recommendation ID NG208/23 Question Anticoagulation and antiplatelet therapy: In adults with biological valve replacement, what effect

  11. The effects of stopping and/or switching drug treatments to control blood glucose levels: In adults with type 2 diabetes, what are the effects of stopping and/or switching drug treatments to control blood glucose levels, and what criteria should inform the decision?

    Recommendation ID NG28/01 Question The effects of stopping and/or switching drug treatments to control blood glucose levels: In adults

  12. Long-term outcomes associated with blood glucose lowering agents: In adults with type 2 diabetes, what are the long‑term effects of blood glucose lowering therapies such as dipeptidyl peptidase‑4 (DPP‑4) inhibitors, sodium–glucose cotransporter‑2 (SGLT2) inhibitors and meglitinides?

    Recommendation ID NG28/04 Question Long-term outcomes associated with blood glucose lowering agents: In adults with type 2 diabetes, what